Clinical Manifestations
Left-Sided Heart Failure
- Pulmonary congestion leads to dyspnea, orthopnea (difficulty breathing when lying flat), and paroxysmal nocturnal dyspnea (waking at night with shortness of breath).
- Patients may exhibit crackles/rales on auscultation, S3 heart sound (ventricular gallop), and decreased exercise tolerance due to inadequate oxygen delivery to tissues.
Key Points
- The severity of orthopnea is measured by the number of pillows needed to sleep comfortably (e.g., 2-pillow orthopnea).
- Pulmonary edema is a medical emergency that presents with severe dyspnea, pink frothy sputum, and respiratory distress.
Right-Sided Heart Failure
- Systemic congestion results in peripheral edema (typically bilateral and dependent), jugular venous distention, hepatomegaly, and ascites.
- Patients may experience weight gain, increased abdominal girth, and nocturia due to mobilization of fluid when supine.
Key Points
- Peripheral edema typically begins in the feet and ankles and progresses upward; it is often worse in the evening and improves with elevation.
- The hepatojugular reflux test (applying pressure to the right upper quadrant causes increased jugular venous distention) is a clinical indicator of right heart failure.
Clinical Scenario: Acute Decompensated Heart Failure
A 72-year-old male with a history of hypertension and coronary artery disease presents to the emergency department with severe shortness of breath that began 2 hours ago. He reports sleeping on 3 pillows at night and has noticed increasing ankle swelling over the past week. On examination, he has bilateral crackles in the lung bases, jugular venous distention, and 2+ pitting edema in both lower extremities. His oxygen saturation is 88% on room air.
Key Assessment Findings: Acute dyspnea, orthopnea, bilateral crackles, JVD, peripheral edema, and hypoxemia are all consistent with acute decompensated heart failure involving both left and right sides.
Pharmacological Management
Medications for Heart Failure with Reduced Ejection Fraction (HFrEF)
- Angiotensin-Converting Enzyme (ACE) Inhibitors (e.g., lisinopril, enalapril): Block the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. They decrease preload and afterload, improve cardiac output, and slow ventricular remodeling.
- Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan): Alternative for patients who cannot tolerate ACE inhibitors due to cough. They block the effects of angiotensin II at receptor sites.
- Beta-Blockers (e.g., carvedilol, metoprolol succinate): Reduce heart rate and contractility, decrease oxygen demand, and prevent harmful effects of chronic sympathetic stimulation. They improve survival and reduce hospitalizations in patients with HFrEF.
- Aldosterone Antagonists (e.g., spironolactone, eplerenone): Block aldosterone receptors, reducing sodium and water retention. They improve survival in moderate to severe heart failure.
- Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) (sacubitril/valsartan): Combination medication that enhances beneficial peptides while blocking angiotensin II effects. It is superior to ACE inhibitors in reducing mortality in HFrEF.
- SGLT2 Inhibitors (e.g., dapagliflozin, empagliflozin): Originally developed for diabetes but shown to reduce heart failure hospitalizations and cardiovascular death regardless of diabetes status.
Key Points
- The cornerstone medications for HFrEF include ACE inhibitors/ARBs/ARNIs, beta-blockers, aldosterone antagonists, and SGLT2 inhibitors—often referred to as guideline-directed medical therapy (GDMT).
- Monitor renal function and potassium levels with ACE inhibitors, ARBs, ARNIs, and aldosterone antagonists due to risk of hyperkalemia and acute kidney injury.
Symptomatic Management
- Diuretics (e.g., furosemide, bumetanide): Promote sodium and water excretion to reduce fluid overload. Loop diuretics are most commonly used for acute symptom relief of congestion.
- Digoxin: Increases myocardial contractility and slows conduction through the AV node. It may improve symptoms and reduce hospitalizations but does not improve survival.
- Vasodilators (e.g., isosorbide dinitrate/hydralazine): Reduce preload and afterload. The combination is particularly beneficial in African American patients with HFrEF.
Key Points
- Diuretics improve symptoms but have not been shown to reduce mortality; they should be used at the lowest effective dose.
- Monitor for electrolyte imbalances (especially hypokalemia and hypomagnesemia) with diuretic therapy, which can increase the risk of digoxin toxicity and arrhythmias.
Memory Aid: Heart Failure Medication Classes
Remember the foundational medications for HFrEF with the acronym "ABCDS":
- A = ACE inhibitors/ARBs/ARNIs
- B = Beta-blockers
- C = Calcium channel blockers (avoided in HFrEF)
- D = Diuretics
- S = Spironolactone (aldosterone antagonist) and SGLT2 inhibitors
Important Medication Safety Alerts
- Never abruptly discontinue beta-blockers in heart failure patients as this can precipitate acute decompensation.
- ACE inhibitors and ARBs are contraindicated in pregnancy (pregnancy category D).
- Monitor digoxin levels closely, especially in elderly patients and those with renal impairment. Therapeutic range is 0.8-2.0 ng/mL.
- Avoid NSAIDs in heart failure patients as they can cause sodium retention, decrease renal function, and reduce the effectiveness of ACE inhibitors and diuretics.
Study Tips and Memory Aids
Heart Failure Signs and Symptoms
Remember the "5 P's" of heart failure:
- Paroxysmal nocturnal dyspnea
- Pink frothy sputum (in pulmonary edema)
- Peripheral edema
- Pulmonary crackles
- Protruding neck veins (JVD)
Left vs. Right Heart Failure
Remember: "Left heart failure goes UP, Right heart failure goes DOWN"
- UP: Left heart failure causes pulmonary congestion with symptoms affecting the upper body (lungs, breathing)
- DOWN: Right heart failure causes systemic congestion with symptoms affecting the lower body (peripheral edema, hepatomegaly, ascites)
NCLEX Preparation Strategies
- Focus on prioritization questions related to heart failure management, particularly recognizing signs of decompensation that require immediate intervention.
- Review medication classes, their mechanisms of action, side effects, and nursing implications, especially for ACE inhibitors, beta-blockers, diuretics, and digoxin.
- Practice questions involving patient education, as this is a major nursing responsibility in heart failure management.
Key Points
- For prioritization questions, remember the ABCs (Airway, Breathing, Circulation) and that acute shortness of breath or decreased oxygen saturation requires immediate attention.
- When answering medication questions, consider not only the therapeutic effects but also monitoring parameters and potential adverse effects.
Quick Knowledge Check
- Which heart sound is characteristic of heart failure? (Answer: S3 gallop)
- What laboratory test is most useful in diagnosing heart failure? (Answer: BNP or NT-proBNP)
- Which medication class should not be abruptly discontinued in heart failure patients? (Answer: Beta-blockers)
- What daily weight gain should prompt a heart failure patient to contact their healthcare provider? (Answer: 2-3 pounds in 24 hours)
- What positioning is best for a patient with acute pulmonary edema? (Answer: High Fowler's position)
Summary of Key Points
Pathophysiology and Assessment
- Heart failure is a complex syndrome where the heart cannot meet the body's metabolic demands, classified as left vs. right-sided and systolic vs. diastolic.
- Left-sided failure presents with pulmonary symptoms (dyspnea, orthopnea, crackles), while right-sided failure presents with systemic congestion (edema, JVD, hepatomegaly).
- Key diagnostic tests include BNP/NT-proBNP, echocardiography, and chest X-ray.
Pharmacological Management
- Guideline-directed medical therapy (GDMT) for HFrEF includes ACE inhibitors/ARBs/ARNIs, beta-blockers, aldosterone antagonists, and SGLT2 inhibitors.
- Symptom management includes diuretics for fluid overload, with careful monitoring of electrolytes and renal function.
- Medication adherence is critical, and abrupt discontinuation of certain medications (especially beta-blockers) can precipitate acute decompensation.
Nursing Management
- Comprehensive assessment includes monitoring vital signs, daily weights, intake and output, and signs of fluid overload.
- Patient education focuses on medication adherence, sodium restriction, fluid management, self-monitoring, and when to seek medical attention.
- Lifestyle modifications include sodium restriction, fluid limitation, physical activity as tolerated, and stress management.
Self-Assessment Checklist